Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Comparative Analysis of Appetite-satiety, Glycemia, Insulin, Incretin Plasmatic Concentrations GLP-1 After the Intake of Non-nutritive Sweeteners in Diabetic Subjects Type 2
| NCT number | NCT03680482 |
| Other study ID # | SUE |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 11, 2016 |
| Est. completion date | August 31, 2017 |
| Verified date | February 2019 |
| Source | University of Chile |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
ABSTRACT
Introduction: There is no current data about the effects of non-nutritive sweeteners (NNS)
about important factors, such as the energy intake, appetite and its relationship in people
with diabetes when tasting sweet. It is highly relevant to compare the effects of NNS intake,
such as, stevia (steviol glycosides) and sucralose, previous to a mixed food on glycemic
response, insulin and plasmatic concentrations of Glucagon-like peptide type 1 (GLP-1) and
ghrelin in subjects with type 2 diabetes mellitus (T2DM).
Objective: To compare the effects of non-nutritive sweeteners intake: stevia (steviol
glyco-sides) and sucralose previous to mixed food on appetite, glycemia, insulin,
ghrelin,incretin plasmatic concentrations GLP-1 in people with T2DM.
Methods: Seventeen subjects with T2DM were studied in 3 different moments and they received 3
treatments: pre-load of water or sucralose or stevia and then offered to consume mixed food
as a test, which provided 332 Kcal and 75 grams of available carbohydrates. Blood samples
were obtained to measure the dependent variables, glycemic and insulin at times -10, 0, 30,
60, 90, 120, 150 and 180 minutes and GLP-1 with ghrelin, at times -10, 0, 30, 90, and 180
minutes. The analogue visual scale questionnaires (VAS) was conducted every 30 minutes in
order to obtain the results of the depend variables: appetite and wish of specific type of
food in a subjective way; appetite, satiety, relax, wish to eat any food, craving for
something sweet, craving for something salty, something tasty, something fatty. Through food
provided ad libi-tum (objective appetite), were obtained the results of: energy,
carbohydrates, proteins and lipid intakes. The statistical analysis applied included the
Shapiro-Wilk's Normality test, repeated measures ANOVA to assess differences among
treatments, Friedman's test followed by Wilcoxon test corrected by Bonferroni as needed. The
degree of association between variables was conducted using the Pearson's or Spearman's
correlation coefficient tests, as requested. A probability value p <0.05 was considered
significant.
| Status | Completed |
| Enrollment | 17 |
| Est. completion date | August 31, 2017 |
| Est. primary completion date | August 8, 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 30 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - Subjects with T2DM - Treatment with metformin and / or diet - Diabetes diagnosed more than 1 year and less than 10 years - Glycosylated hemoglobin (HbA1c) less than 9% - Body mass index (BMI) =25 kg / m2 and <39.9 kg / m2 Exclusion Criteria: - Subjects who consume any other drug or dietary supplement that may interfere with appetite or satiety or their post-prandial glycemic and hormonal responses - Subjects with illness; acute, cardio-vascular significant, psychological, neurological, renal, alcohol or drug abuse - Subjects that have aversion or allergy to foods / sweeteners used in test meals. - Subjects with eating disorders and who have had gastrointestinal surgery of type: bariatric surgery, gastrectomy, Whip-ple or intestinal resections |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Chile | Sociedad Chilena de Nutrición |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | incretin plasmatic concentrations GLP-1 in blood | Area under the curve was built for each subjects after steviol or sucralose or water intake. | Three Hours | |
| Other | ghrelin response in blood | Area under the curve was built for each subjects after steviol or sucralose or water intake. | Three Hours | |
| Other | The analogue visual scale questionnaires (VAS) | Used to measure the appetite sensation includes three characteristic concepts; hunger, fullness and satiety. Understanding hunger for: vital and indispensable physiological need to nourish our body; Fullness: State that invites to stop eating; and satiety as: Sensation of satisfaction. The visual analog scale (VAS) of 10 cm in length will be used with words anchored at each end, which expresses the most positive rating (value 10 cm) and the most negative (0 cm). It will be used to evaluate hunger, satiety, fullness, prospective food consumption, desire to eat something sweet, salty, tasty or fatty, scale whose reference is "Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24 (1): 38-48. was conducted every 30 minutes in order to obtain the results of the depend variables. |
30 minutes | |
| Other | Through food provided ad libitum (objective appetite) | were obtained the results of: energy, carbohydrates, proteins and lipid intakes. | 30 minutes | |
| Primary | glycemic response in blood | Area under the curve was built for each subjects after steviol or sucralose or water intake. | Three hours | |
| Secondary | Insulin response in blood | Area under the curve was built for each subjects after steviol or sucralose or water intake. | Three Hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |